A rapid and efficient method developed to create stem-cell-based 3D mini-organs derived from the cells of patients offers a way to evaluate personalized treatments using RNA therapies for rare genetic ...
BMO Capital Markets has upgraded US Steel's stock from Market Perform to Outperform on Wednesday. U. S. Steel broke ground on the Mini-Mill facility in 2022 and plans to complete construction this ...
U.S. Steel (NYSE:X) on Thursday posted a net loss of $116 million, or $0.52 a share, for the first quarter of 2025, as seasonal logistics constraints and weak steel prices weighed on performance. On ...